Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild to Moderate Atopic Dermatitis in Two Phase 3 Trials (INTEGUMENT-1 and INTEGUMENT-2). (2023). SKIN The Journal of Cutaneous Medicine, 7(4), s220. https://doi.org/10.25251/skin.7.supp.220